Sidra Medicine Establishes Gene Therapy Center for Rare Genetic Diseases in Qatar

A Gene Therapy Center has been established by Sidra Medicine, a Qatar Foundation member, to treat uncommon genetic illnesses such Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA).

The announcement was made at Arab Health 2025, where Sidra Medicine will showcase its global patient care initiatives, including flagship services like the Heart Center, gene therapy, and reproductive medicine, among others.

Prof Tawfeg Ben-Omran, division chief of Genetic and Genomic Medicine at Sidra Medicine, said: “In response to the overwhelming demand from neighbouring countries, the establishment of the Gene Therapy Center is a crucial step in meeting the needs of families seeking cutting-edge treatments for SMA and DMD. As a Qatari institution, our goal is to create a regional centre of excellence, where children from across the Arab world can access advanced therapies without the need to travel long distances, bringing world-class care closer to home.”

Learn More: Will Elevidys Receive Approval from the European Medicines Agency (EMA)?

LEAVE A REPLY

Please enter your comment!
Please enter your name here


Hot Topics

Related Articles